ARTV
Price
$4.03
Change
+$0.16 (+4.13%)
Updated
Feb 6 closing price
Capitalization
98.92M
49 days until earnings call
Intraday BUY SELL Signals
GLMD
Price
$0.66
Change
+$0.06 (+10.00%)
Updated
Feb 6 closing price
Capitalization
3.71M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs GLMD

Header iconARTV vs GLMD Comparison
Open Charts ARTV vs GLMDBanner chart's image
Artiva Biotherapeutics
Price$4.03
Change+$0.16 (+4.13%)
Volume$145.05K
Capitalization98.92M
Galmed Pharmaceuticals
Price$0.66
Change+$0.06 (+10.00%)
Volume$176.47K
Capitalization3.71M
ARTV vs GLMD Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
GLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. GLMD commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and GLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (ARTV: $4.03 vs. GLMD: $0.66)
Brand notoriety: ARTV and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 11% vs. GLMD: 161%
Market capitalization -- ARTV: $98.92M vs. GLMD: $3.71M
ARTV [@Biotechnology] is valued at $98.92M. GLMD’s [@Biotechnology] market capitalization is $3.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileGLMD’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • GLMD’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than GLMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while GLMD’s TA Score has 4 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 4 bearish.
  • GLMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а +3.60% price change this week, while GLMD (@Biotechnology) price change was -6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

GLMD is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($98.9M) has a higher market cap than GLMD($3.71M). ARTV YTD gains are higher at: -6.061 vs. GLMD (-11.539). GLMD has higher annual earnings (EBITDA): -7.11M vs. ARTV (-83.6M). ARTV has more cash in the bank: 123M vs. GLMD (19.1M). GLMD has less debt than ARTV: GLMD (41K) vs ARTV (11.7M). ARTV (0) and GLMD (0) have equivalent revenues.
ARTVGLMDARTV / GLMD
Capitalization98.9M3.71M2,663%
EBITDA-83.6M-7.11M1,175%
Gain YTD-6.061-11.53953%
P/E RatioN/A0.02-
Revenue00-
Total Cash123M19.1M644%
Total Debt11.7M41K28,537%
FUNDAMENTALS RATINGS
GLMD: Fundamental Ratings
GLMD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARTVGLMD
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
86%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
GLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRI2.390.20
+9.13%
GRI Bio Inc.
TRMD24.900.76
+3.15%
TORM plc
MAS72.871.76
+2.48%
Masco Corp
YHNA10.660.01
+0.09%
YHN Acquisition I Ltd
CIVB24.83-0.04
-0.16%
Civista Bancshares

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been closely correlated with QNCX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARTV jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+4.13%
QNCX - ARTV
94%
Closely correlated
-4.79%
MREO - ARTV
89%
Closely correlated
+13.20%
TPST - ARTV
89%
Closely correlated
+7.62%
CALC - ARTV
89%
Closely correlated
-1.77%
BDRX - ARTV
82%
Closely correlated
-4.62%
More

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with ARTV. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+11.58%
ARTV - GLMD
68%
Closely correlated
+4.13%
TPST - GLMD
67%
Closely correlated
+7.62%
MREO - GLMD
65%
Loosely correlated
+13.20%
RZLT - GLMD
64%
Loosely correlated
+6.85%
IMRN - GLMD
63%
Loosely correlated
+3.31%
More